GERI-BP002-A, novel inhibitor of Acyl-CoA : cholesterol acyltransferase produced by Aspergillus fumigatus F93

Cited 13 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorYoung Kook Kim-
dc.contributor.authorHyun Woo Lee-
dc.contributor.authorKwang Hee Son-
dc.contributor.authorByoung-Mog Kwon-
dc.contributor.authorTae Sook Jeong-
dc.contributor.authorDong-Heui Lee-
dc.contributor.authorJongheon Shin-
dc.contributor.authorYoungwan Seo-
dc.contributor.authorSung Uk Kim-
dc.contributor.authorSong Hae Bok-
dc.date.accessioned2017-04-19T08:45:28Z-
dc.date.available2017-04-19T08:45:28Z-
dc.date.issued1996-
dc.identifier.issn0021-8820-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/3754-
dc.description.abstractA new inhibitor of acyl-CoA : cholesterol acyltransfcrase (ACAT), designated GERI-BP002-A, was isolated from the culture broth of Aspergillus fumigalus F93 by acetone extraction, EtOAc extraction, SiO2 column chromatography and reverse phase HPLC. Spectroscopic analyses of the compound identified bis (2-hydroxy-3-tert-butyl-5-methylphenyl) methane as the structure and its molecular weight and formula to be 340 and C23H32O2, respectively. GERI-BP002-A inhibited ACAT activity by 50% at the concentration of 50 μM in an enzyme assay system using rat liver microsomes.-
dc.publisherSpringer-Nature Pub Group-
dc.titleGERI-BP002-A, novel inhibitor of Acyl-CoA : cholesterol acyltransferase produced by Aspergillus fumigatus F93-
dc.title.alternativeGERI-BP002-A, novel inhibitor of Acyl-CoA : cholesterol acyltransferase produced by Aspergillus fumigatus F93-
dc.typeArticle-
dc.citation.titleJournal of Antibiotics-
dc.citation.number1-
dc.citation.endPage36-
dc.citation.startPage31-
dc.citation.volume49-
dc.contributor.affiliatedAuthorYoung Kook Kim-
dc.contributor.affiliatedAuthorHyun Woo Lee-
dc.contributor.affiliatedAuthorKwang Hee Son-
dc.contributor.affiliatedAuthorByoung-Mog Kwon-
dc.contributor.affiliatedAuthorTae Sook Jeong-
dc.contributor.affiliatedAuthorSung Uk Kim-
dc.contributor.affiliatedAuthorSong Hae Bok-
dc.contributor.alternativeName김영국-
dc.contributor.alternativeName이현우-
dc.contributor.alternativeName손광희-
dc.contributor.alternativeName권병목-
dc.contributor.alternativeName정태숙-
dc.contributor.alternativeName이동휘-
dc.contributor.alternativeName신종헌-
dc.contributor.alternativeName서영완-
dc.contributor.alternativeName김성욱-
dc.contributor.alternativeName복성해-
dc.identifier.bibliographicCitationJournal of Antibiotics, vol. 49, no. 1, pp. 31-36-
dc.identifier.doi10.7164/antibiotics.49.31-
dc.description.journalClassY-
Appears in Collections:
Division of A.I. & Biomedical Research > Microbiome Convergence Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.